AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim-M4 Tablet PR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (1000mg)

Overview Endoglim-M4 Tablet PR

Diabetol Duo tablets are anti-diabetic medications, a dual-drug formulation for adult type 2 diabetes management. They help regulate blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial; abrupt cessation, without physician consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Endoglim-M4 Tablet PR

Managing type 2 diabetes

Major Benefits of Endoglim-M4 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Endoglim-M4 Tablet PR with food.

Common Side effects of Endoglim-M4 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Endoglim-M4 Tablet PR:

Follow your physician's instructions or consult the product labeling for dosage guidance. Administer Endoglim-M4 Tablet PR with a meal.

How Endoglim-M4 Tablet PR works:

Endoglim-M4 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Endoglim-M4 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim-M4 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Administering Endoglim-M4 Tablet PR to breastfeeding individuals is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Endoglim-M4 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim-M4 Tablet PR cautiously, potentially requiring dose modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Endoglim-M4 Tablet PR :

Should you forget a dose of Endoglim-M4 Tablet PR, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Endoglim-M4 Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Endoglim-M4 Tablet PR

Maintain this medication within its original, securely sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Endoglim-M4 Tablet PR administration can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also referred to as MALA (Metformin-associated lactic acidosis). While uncommon with metformin, this adverse reaction poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may encompass myalgia, weakness, vertigo, fatigue, acral coldness, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Endoglim-M4 Tablet PR use and seek immediate medical attention.
Endoglim-M4 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a suitable diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Endoglim-M4 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged administration of Endoglim-M4 Tablet PR can indeed lead to Vitamin B12 deficiency. This medication impairs the gastrointestinal absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include supplemental Vitamin B12 intake at least annually.
Indeed, Endoglim-M4 Tablet PR can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition may encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It is advisable to always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Endoglim-M4 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption may also heighten the likelihood of lactic acidosis.
Endoglim-M4 Tablet PR
163
MRP 199
18% off